申请人:Schlienger Nathalie
公开号:US20070004679A1
公开(公告)日:2007-01-04
Disclosed herein are bicycloaryl compounds of Formula (I) that selectively modulate nuclear receptors, preferably the androgen receptor, or a pharmaceutically acceptable salt, ester, amide, or prodrug thereof, and methods of treating disease comprising administering a compound of Formula (I) to a patient in need thereof.
本文公开了一种公式(I)的双环芳基化合物,其选择性调节核受体,优选为雄激素受体,或其药学上可接受的盐、酯、酰胺或前药,以及包括向需要治疗的患者给予公式(I)化合物的治疗疾病的方法。